COAG
+$0
221,188 sh
RA CAPITAL MANAGEMENT, L.P.
10% Owner, Director · SEC CIK 1346824
Insider at
HOWL Werewolf Therapeutics, Inc.
ARTV Artiva Biotherapeutics, Inc.
PBLS Parabilis Medicines, Inc.
NKTX Nkarta, Inc.
BCAX Bicara Therapeutics Inc.
CLYM Climb Bio, Inc.
ABOS Acumen Pharmaceuticals, Inc.
TYRA Tyra Biosciences, Inc.
COAG Hemab Therapeutics Holdings, Inc.
ACRV Acrivon Therapeutics, Inc.
ACET Adicet Bio, Inc.
PRLD Prelude Therapeutics Inc
VOR Vor Biopharma Inc.
MLYS Mineralys Therapeutics, Inc.
WVE Wave Life Sciences Ltd.
EVMN Evommune, Inc.
SGP SpyGlass Pharma, Inc.
CDTX Cidara Therapeutics, Inc.
FULC Fulcrum Therapeutics, Inc.
SION Sionna Therapeutics, Inc.
Advertisement
Buy track record
How this insider's open-market purchases have performed36%
of buys now in profit
12 up · 21 down
Avg return since buy+27.5%
Median return−0.1%
Best trade+401.7%
Worst trade−26.9%
Buys scored33
Average return by holding period — separates good entry timing from riding one long winner
After 1 month
+9.4%
75% won · 28 trades
After 3 months
+52.9%
67% won · 9 trades
After 6 months
+327.8%
100% won · 2 trades
After 12 months
—
not elapsed yet
| Date | Company | 90d trend | Buy price | Value | ΔOwn | 1M | 3M | 6M | 12M | To date |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | ARTV | $8 | $4.34M | +3.5% | — | — | — | — | +6.7% | |
| Jun 10, 2026 | ARTV | $7 | $721 | — | — | — | — | — | +15.1% | |
| Jun 9, 2026 | ARTV | $7 | $3.31M | +3.2% | — | — | — | — | +17.5% | |
| May 20, 2026 | COAG | $25 | $24.8K | — | — | — | — | — | −5.6% | |
| May 19, 2026 | COAG | $25 | $94.9K | +0.1% | — | — | — | — | −1.8% | |
| May 12, 2026 | COAG | $25 | $159K | +0.1% | −3.6% | — | — | — | −3.6% | |
| May 11, 2026 | ARTV | $12 | $75M | +75% | −24.5% | — | — | — | −19.4% | |
| May 11, 2026 | COAG | $24 | $346.2K | +0.2% | +7.8% | — | — | — | −0.1% | |
| May 11, 2026 | COAG | $25 | $643K | +0.4% | +7.8% | — | — | — | −0.1% | |
| May 8, 2026 | COAG | $25 | $37K | — | +1.7% | — | — | — | −0.6% | |
| May 7, 2026 | COAG | $24 | $192.8K | +0.1% | −0.7% | — | — | — | −3.0% | |
| May 7, 2026 | COAG | $25 | $49.5K | — | −0.7% | — | — | — | −3.0% | |
| May 6, 2026 | COAG | $24 | $347.3K | +0.2% | +2.2% | — | — | — | −0.1% | |
| May 6, 2026 | COAG | $25 | $1.33M | +0.9% | +2.2% | — | — | — | −0.1% | |
| May 5, 2026 | COAG | $25 | $2.14M | +1.4% | +1.2% | — | — | — | −0.1% | |
| May 5, 2026 | COAG | $25 | $256.7K | +0.2% | +1.2% | — | — | — | −0.1% | |
| May 4, 2026 | COAG | $18 | $45.74M | +70% | +0.3% | — | — | — | −1.4% | |
| May 4, 2026 | COAG | $18 | $2.41M | +60% | +0.3% | — | — | — | −1.4% | |
| Mar 30, 2026 | MLYS | $24 | $1.41M | +1.0% | +13.4% | — | — | — | +2.2% | |
| Mar 30, 2026 | WVE | $7 | $6.31M | +3.7% | +6.6% | — | — | — | −10.7% | |
| Mar 27, 2026 | MLYS | $24 | $7.35M | +5.7% | +14.0% | — | — | — | +1.5% | |
| Mar 27, 2026 | WVE | $6 | $16.05M | +11% | +8.9% | — | — | — | −7.2% | |
| Mar 26, 2026 | WVE | $6 | $30.02M | +27% | +11.9% | — | — | — | −4.7% | |
| Mar 26, 2026 | WVE | $6 | $2.24M | +1.5% | +11.9% | — | — | — | −4.7% | |
| Feb 26, 2026 | BCAX | $16 | $4.8M | +7.0% | +12.6% | +30.8% | — | — | +29.1% | |
| Feb 20, 2026 | ACET | $7 | $543.4K | +6.7% | −3.1% | +8.7% | — | — | +16.0% | |
| Feb 19, 2026 | ACET | $7 | $535.5K | +7.2% | −5.0% | −2.6% | — | — | +11.3% | |
| Feb 18, 2026 | ACET | $7 | $525K | +7.8% | −1.8% | +6.2% | — | — | +17.3% | |
| Feb 9, 2026 | SGP | $16 | $55.07M | +136% | +3.6% | −9.2% | — | — | −26.9% | |
| Feb 9, 2026 | SGP | $16 | $3.97M | +14% | +3.6% | −9.2% | — | — | −26.9% | |
| Jan 5, 2026 | CLYM | $4 | $24.9K | +0.2% | +31.4% | +90.4% | — | — | +226.0% | |
| Dec 12, 2025 | CLYM | $3 | $290.2K | +3.1% | +56.7% | +142.0% | +281.3% | — | +284.7% | |
| Dec 11, 2025 | CLYM | $2 | $464.6K | +6.9% | +104.3% | +218.7% | +374.3% | — | +401.7% |
How this is calculated. We score only open-market purchases (SEC code
P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 33 scored trades, treat this as a small sample, not a verdict.
Advertisement
Open-market buys
$266.03M
33 trades
Open-market sells
$115.14M
66 trades
Net flow
+$150.89M
Net buying
Total filings
113
transactions shown
Full transaction history
All Form 4 activity across every company, newest firstCOAG
Ra Capital Management, L.p., COAG's 10% owner, spent $45.74M of their own money on 2.54M shares at $18, growing their stake 70%. Their tracked buys have a 17% win rate.
+$45.74M
2.54M sh @ $18
COAG
Ra Capital Management, L.p., COAG's 10% owner, spent $2.41M of their own money on 133,750 shares at $18, growing their stake 60%. Their tracked buys have a 17% win rate.
+$2.41M
133,750 sh @ $18
ACET
−$0
250,000 sh
PRLD
−$0
1.41M sh
Advertisement
VOR
−$2.6M
165,150 sh @ $16
ACRV
+$7M
3.89M sh @ $2
VOR
−$2.71M
171,963 sh @ $16
VOR
−$7.46M
458,411 sh @ $16
VOR
−$858.8K
53,644 sh @ $16
VOR
−$2.46M
153,735 sh @ $16
VOR
−$8.57M
530,610 sh @ $16
VOR
−$13K
828 sh @ $16
VOR
−$2.24M
135,201 sh @ $17
VOR
−$5.76M
353,242 sh @ $16
VOR
−$2.21M
130,862 sh @ $17
VOR
−$8.88M
537,754 sh @ $17
VOR
−$774.2K
44,728 sh @ $17
VOR
−$125.3K
6,775 sh @ $19
VOR
−$4.71M
258,475 sh @ $18
VOR
−$29.1K
1,525 sh @ $19
MLYS
Ra Capital Management, L.p., MLYS's Director, spent $1.41M of their own money on 58,300 shares at $24, growing their stake 1%. Their tracked buys have a 17% win rate.
+$1.41M
58,300 sh @ $24
WVE
Ra Capital Management, L.p., WVE's 10% owner, spent $6.31M of their own money on 971,091 shares at $7, growing their stake 4%. Their tracked buys have a 17% win rate.
+$6.31M
971,091 sh @ $7
MLYS
Ra Capital Management, L.p., MLYS's Director, spent $7.35M of their own money on 310,700 shares at $24, growing their stake 6%. Their tracked buys have a 17% win rate.
+$7.35M
310,700 sh @ $24
WVE
Ra Capital Management, L.p., WVE's 10% owner, spent $16.05M of their own money on 2.5M shares at $6, growing their stake 11%. Their tracked buys have a 17% win rate.
+$16.05M
2.5M sh @ $6
WVE
Ra Capital Management, L.p., WVE's 10% owner, spent $30.02M of their own money on 4.95M shares at $6, growing their stake 27%. Their tracked buys have a 17% win rate.
+$30.02M
4.95M sh @ $6
WVE
Ra Capital Management, L.p., WVE's 10% owner, spent $2.24M of their own money on 351,224 shares at $6, growing their stake 2%. Their tracked buys have a 17% win rate.
+$2.24M
351,224 sh @ $6
ABOS
+$20M
6.06M sh @ $3
BCAX
Ra Capital Management, L.p., BCAX's 10% owner, spent $4.8M of their own money on 300,000 shares at $16, growing their stake 7%. Their tracked buys have a 17% win rate.
+$4.8M
300,000 sh @ $16
ACET
Ra Capital Management, L.p., ACET's 10% owner, spent $543.4K of their own money on 74,751 shares at $7, growing their stake 7%. Their tracked buys have a 17% win rate.
+$543.4K
74,751 sh @ $7
Frequently asked questions
How is RA CAPITAL MANAGEMENT, L.P.'s win rate calculated?
We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.
Why are some buys not included in the score?
A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.
What do the 1M / 3M / 6M / 12M columns mean?
They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.
Does a high win rate mean I should copy this insider?
No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.
Where does this data come from?
Trades come from RA CAPITAL MANAGEMENT, L.P.'s SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.